Alivus Life Sciences Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 711.90 | 686.82 | 602.70 |
| Operating Expense | 474.59 | 467.27 | 408.81 |
| Net Profit | 162.66 | 150.26 | 130.03 |
| Net Profit Margin | 22.85% | 21.88% | 21.57% |
| Earning Per Share | 13.23 | 12.25 | 10.60 |
| EBIDTA | 235.26 | 225.33 | 189.74 |
| Effective Tax Rate | 21.53% | 24.56% | 20.60% |
Particulars
Mar 2026
Revenue711.90
Operating Expense474.59
Net Profit162.66
Net Profit Margin22.85
Earning Per Share13.23
EBIDTA235.26
Effective Tax Rate21.53
